Guidelines for chemotherapy of biliary tract and ampullary carcinomas - Wikidata - awgldk - TriplyDB

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

http://www.wikidata.org/entity/Q34588361

about

Progression of targeted therapy in advanced cholangiocarcinoma The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival.Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study.Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection Targeted therapy for biliary tract cancer.Targeted therapy in biliary tract cancer: 2009 update.Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review.Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points.Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.Actual status of clinical diagnosis in patients with primary gallbladder cancer associated with adenomyomatosis.Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy

P2860

Q27016150-FB0BB9CD-D2B8-4DB3-A218-ABC78F362484 Q30250054-3FF4C217-1334-4F35-9470-9663466E75BB Q33428545-88768398-0F5C-4528-BF34-C046B709889D Q33656703-7BA13D4F-73F5-487C-9229-C836FF64B426 Q33691544-4FC1D59A-F5CA-4828-9FF5-DAB2A10FD7BA Q36020131-F2FE45AD-3A6B-4474-8C72-15C234A42DC1 Q36091760-BC643E55-1586-42F9-91EF-C482E55A4BC4 Q37132750-14F955CB-6200-4AF3-9856-1A6BF7F75C2C Q37650623-BC2178AE-1B24-4FCE-BEC8-762ABEC68627 Q37977363-FDABD0FF-1EE4-4D98-9671-29B7B019EACF Q38131835-554FA534-4722-4B30-9F8E-F22145F313BB Q38381904-260D1B73-9D1B-4E76-957A-0BFF95AAE2EE Q38383198-11697918-EDFE-4DE5-9AC6-76470F7E7136 Q41140456-948E9F43-1044-42D2-92CD-BA203431138A Q41479806-62ECFB7A-FCEC-43B1-81B5-070E246B885E Q43722348-F638C4D9-B098-45DE-991C-02915C42657F Q44488107-6BE34194-A8CB-41C6-B1CF-AA28B5CD60A5 Q45307308-C06F7018-F704-4D65-AF1C-A6034B53EDB5 Q58794884-5E27F630-92B1-496B-8CF0-873527626411

P2860

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

http://www.wikidata.org/entity/Q34588361

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@ast

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@en

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@nl

type

label

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@ast

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@en

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@nl

prefLabel

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@ast

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@en

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@nl

P1433

Q34588361-CCB9A566-9269-4C14-8A40-98A1802772F2

P1476

Q34588361-DFEDD535-CDE0-4BD1-83C8-BA0AC2F2A71B

P2093

Q34588361-1295918E-092F-46B2-8103-35AD74AFDDD2

Q34588361-2763130B-F9BF-48FB-9807-77F88D70068C

Q34588361-4532BE88-B2ED-48B8-B6EF-AAF145A8BC71

Q34588361-4B7BE0FB-F0D1-4765-B9EC-031EA7D32318

Q34588361-5960454B-0121-447F-862C-1852B3AE99F3

Q34588361-5ABD1585-E2C7-43C1-A204-1A216FED2C4E

Q34588361-5D78E643-C718-49DF-B39F-F9C506A685FD

Q34588361-67524DEC-DED8-482A-8A7C-E351156469A8

Q34588361-6AC40AC0-6B58-4A01-87E4-D2D3692D878C

Q34588361-6F8F164F-4BEC-4867-B3C3-09BB22255C4C

P2860

Q34588361-0421EDE7-98AE-45EC-89D9-0AC986C79B08

Q34588361-04EF2274-E3A4-4B07-BA34-C839272B74E7

Q34588361-0748E49D-C66C-4CA8-9612-BF841E3D3977

Q34588361-0981FA5A-6DCC-4E39-98B4-82568343FBB8

Q34588361-113B127E-07F8-443D-ADA3-0C0F3524AADB

Q34588361-17AB1A9C-91E1-43C0-B67C-13DA804E13BC

Q34588361-233C8968-6CFF-496F-9356-B283D6552F8D

Q34588361-24675D73-5AC0-4A51-A350-0D450FF54812

Q34588361-29066C68-298F-4A4E-B15D-278986C7B2F1

Q34588361-2D519828-F5D3-4A45-A091-BFC94C2EBADC

P304

Q34588361-872B6CFA-F07A-4101-B20C-1EC96AB2FAD3

P31

Q34588361-E46FEAA3-F118-4B68-B508-278C8C15E1E8

P356

Q34588361-32B6E6F0-C850-4C1C-AD81-C06822FB9513

P433

Q34588361-24C4B335-F809-4BB4-BC02-D62037625973

P478

Q34588361-0D82D2A1-AA80-46A6-BC33-FBC719BBF06C

P577

Q34588361-57513A64-7254-4E70-8D84-EB574E012B97

P5875

Q34588361-677BD16F-1255-4102-AC70-7FC22D5C0606

P698

Q34588361-B23CCF4B-136C-4515-B9BA-E00F2DD94DB7

P921

Q34588361-AEA88DCD-332A-41DB-9FBC-D6CAD5DB3318

P932

Q34588361-EF35E394-A2D2-4A4C-A0B7-283FB94495F9

P356

S00534-007-1280-Z

P1433

Journal of Hepato-Biliary-Pancreatic Surgery

P1476

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

@en

P2093

Fumihiko Miura

http://www.w3.org/2001/XMLSchema#string

Fumio Kimura

http://www.w3.org/2001/XMLSchema#string

Hideyuki Yoshitomi

http://www.w3.org/2001/XMLSchema#string

Hiroya Saito

http://www.w3.org/2001/XMLSchema#string

Hodaka Amano

http://www.w3.org/2001/XMLSchema#string

Japan Society of Clinical Oncology

http://www.w3.org/2001/XMLSchema#string

Japanese Association of Biliary Surgery

http://www.w3.org/2001/XMLSchema#string

Japanese Society of Hepato-Biliary-Pancreatic Surgery

http://www.w3.org/2001/XMLSchema#string

Junji Furuse

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Tsukada

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas.

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

A phase II study of gemcitabine in gallbladder carcinoma.

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma.

A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.

P304

55-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00534-007-1280-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5576935

http://www.w3.org/2001/XMLSchema#string

P698

18274844

http://www.w3.org/2001/XMLSchema#string

P921

P932

2794344

http://www.w3.org/2001/XMLSchema#string